Your browser doesn't support javascript.
loading
Seroprevalence of SARS-CoV-2 antibodies during the third wave of COVID-19 in the Seoul metropolitan area of Korea.
Yoon, Kyuhyun; Kim, Jayeun; Peck, Kyong Ran; Kim, Hyun Soo; Lee, Hyukmin; Hwang, Yoo-Sung; Lee, Soon Young; Cho, Sung-Il; Lee, Hun Jae; Kim, Yeong-Gyeong; Kim, Byoungguk; Lee, June-Woo; Kim, Ah-Ra; Do, Hyeon Nam; Kim, Dong-Hyun.
Affiliation
  • Yoon K; Institute of Health and Environment, Seoul National University, Seoul, Korea.
  • Kim J; Korea Institute of Child Care and Education, Seoul, Korea.
  • Peck KR; Division of Infectious Diseases, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Kim HS; Department of Laboratory Medicine, Hallym University Dongtan Sacred Heart Hospital, Hallym University College of Medicine, Hwaseong, Korea.
  • Lee H; Department of Laboratory Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
  • Hwang YS; Seegene Medical Foundation, Seoul, Korea.
  • Lee SY; Department of Preventive Medicine and Public Health, Ajou University School of Medicine, Suwon, Korea.
  • Cho SI; Department of Public Health Science, Graduate School of Public Health, Seoul National University, Seoul, Korea.
  • Lee HJ; Department of Social and Preventive Medicine, Inha University College of Medicine, Incheon, Korea.
  • Kim YG; Department of Public Health Science, Graduate School of Public Health, Seoul National University, Seoul, Korea.
  • Kim B; Division of Vaccine Clinical Research Center for Vaccine Research, National Institute of Infectious Diseases, National Institute of Health (NIH), Korea Disease Control and Prevention Agency (KDCA), Cheongju, Korea.
  • Lee JW; Division of Vaccine Clinical Research Center for Vaccine Research, National Institute of Infectious Diseases, National Institute of Health (NIH), Korea Disease Control and Prevention Agency (KDCA), Cheongju, Korea.
  • Kim AR; Division of Vaccine Clinical Research Center for Vaccine Research, National Institute of Infectious Diseases, National Institute of Health (NIH), Korea Disease Control and Prevention Agency (KDCA), Cheongju, Korea.
  • Do HN; Division of Vaccine Clinical Research Center for Vaccine Research, National Institute of Infectious Diseases, National Institute of Health (NIH), Korea Disease Control and Prevention Agency (KDCA), Cheongju, Korea.
  • Kim DH; Department of Social and Preventive Medicine, Hallym University College of Medicine, Chuncheon, Korea.
Epidemiol Health ; 44: e2022085, 2022.
Article in En | MEDLINE | ID: mdl-36228670
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 Serological Testing / COVID-19 Type of study: Risk_factors_studies Limits: Female / Humans Country/Region as subject: Asia Language: En Journal: Epidemiol Health Year: 2022 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 Serological Testing / COVID-19 Type of study: Risk_factors_studies Limits: Female / Humans Country/Region as subject: Asia Language: En Journal: Epidemiol Health Year: 2022 Document type: Article Country of publication: